RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis-Reference-Cited by-同舟云学术

RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis

Published:2016-04-01 Issue:5 Volume:15 Page:946-957
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Brünker Peter,Wartha Katharina,Friess Thomas,Grau-Richards Sandra,Waldhauer Inja,Koller Claudia Ferrara,Weiser Barbara,Majety Meher,Runza Valeria,Niu Huifeng,Packman Kathryn,Feng Ningping,Daouti Sherif,Hosse Ralf J.,Mössner Ekkehard,Weber Thomas G.,Herting Frank,Scheuer Werner,Sade Hadassah,Shao Cuiying,Liu Bin,Wang Peng,Xu Gary,Vega-Harring Suzana,Klein Christian,Bosslet Klaus,Umaña Pablo

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution;Journal of Hematology & Oncology;2024-09-02

2. Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment;Annual Review of Chemical and Biomolecular Engineering;2024-07-24

3. Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer Therapy;ACS Nano;2024-06-24

4. Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r future;Frontiers in Pharmacology;2024-05-30

5. A phase separation-fortified bi-specific adaptor for conditional tumor killing;Science China Life Sciences;2024-03-28